STAT

At life’s end, an unconventional therapy puts a woman at ease

Nothing was ever easy in this woman’s life. The way to help her at the end was unexpected.

Nothing was ever easy in this woman’s life.

She felt trapped — trapped in a life with the wrong parents, surrounded by the wrong people, and, as a result, she had a pregnancy with the wrong man for her and her child.

But some lives are fulcrums on which generational histories tilt. She decided hers would be such a life.

We’ll give her a pseudonym, Mariel, to protect the privacy of her daughter, who we’ll call Lina.

Mariel was a quietly expressive Latina in her mid-20s with straight brown hair and deep-set brown eyes and high cheekbones, and she dressed simply but always with

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks